{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T08:43:04Z","timestamp":1770194584982,"version":"3.49.0"},"publisher-location":"Berlin, Heidelberg","reference-count":198,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642287190","type":"print"},{"value":"9783642287206","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-3-642-28720-6_201","type":"book-chapter","created":{"date-parts":[[2014,2,12]],"date-time":"2014-02-12T06:18:25Z","timestamp":1392185905000},"page":"647-670","source":"Crossref","is-referenced-by-count":9,"title":["A Translational Approach to Novel Medication Development for Protracted Abstinence"],"prefix":"10.1007","author":[{"given":"Barbara J.","family":"Mason","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda E.","family":"Higley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,2,18]]},"reference":[{"key":"201_CR1","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.addbeh.2004.12.011","volume":"30","author":"G Addolorato","year":"2005","unstructured":"Addolorato G, Leggio L, Abenavoli L, Gasbarrini G (2005) Neurobiochemical and clinical aspects of craving in alcohol addiction: a review. Addict Behav 30:1209\u20131224","journal-title":"Addict Behav"},{"key":"201_CR2","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1097\/01.ALC.0000176356.97620.84","volume":"29","author":"B Adinoff","year":"2005","unstructured":"Adinoff B, Junghanns K, Kiefer F, Krishnan-Sarin S (2005a) Suppression of the HPA axis stress-response: implications for relapse. Alcohol Clin Exp Res 29:1351\u20131355","journal-title":"Alcohol Clin Exp Res"},{"key":"201_CR3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/01.ALC.0000158940.05529.0A","volume":"29","author":"B Adinoff","year":"2005","unstructured":"Adinoff B, Krebaum SR, Chandler PA, Ye W, Brown MB, Williams MJ (2005b) Dissection of hypothalamic-pituitary-adrenal axis pathology in 1-month-abstinent alcohol-dependent men, part 1: adrenocortical and pituitary glucocorticoid responsiveness. Alcohol Clin Exp Res 29:517\u2013527","journal-title":"Alcohol Clin Exp Res"},{"key":"201_CR4","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1176\/ajp.148.8.1023","volume":"148","author":"B Adinoff","year":"1991","unstructured":"Adinoff B, Risher-Flowers D, De Jong J, Ravitz B, Bone GH, Nutt DJ, Roehrich L, Martin PR, Linnoila M (1991) Disturbances of hypothalamic-pituitary-adrenal axis functioning during ethanol withdrawal in six men. Am J Psychiatry 148:1023\u20131025","journal-title":"Am J Psychiatry"},{"key":"201_CR5","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1097\/01.ALC.0000087581.13912.64","volume":"27","author":"B Adinoff","year":"2003","unstructured":"Adinoff B, Ruether K, Krebaum S, Iranmanesh A, Williams MJ (2003) Increased salivary cortisol concentrations during chronic alcohol intoxication in a naturalistic clinical sample of men. Alcohol Clin Exp Res 27:1420\u20131427","journal-title":"Alcohol Clin Exp Res"},{"key":"201_CR6","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1600-0447.1982.tb06720.x","volume":"66","author":"C Alling","year":"1982","unstructured":"Alling C, Balldin J, Bokstrom K, Gottfries CG, Karlsson I, Langstrom G (1982) Studies on duration of a late recovery period after chronic abuse of ethanol. A cross-sectional study of biochemical and psychiatric indicators. Acta Psychiatr Scand 66:384\u2013397","journal-title":"Acta Psychiatr Scand"},{"key":"201_CR7","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890423349","volume-title":"Diagnostic and statistical manual of mental disorders, fourth edition, text revision","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, fourth edition, text revision. American Psychiatric Association, Washington, DC"},{"key":"201_CR8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0306-4603(97)00024-5","volume":"23","author":"HM Annis","year":"1998","unstructured":"Annis HM, Sklar SM, Moser AE (1998) Gender in relation to relapse crisis situations, coping, and outcome among treated alcoholics. Addict Behav 23:127\u2013131","journal-title":"Addict Behav"},{"key":"201_CR9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00213-003-1720-7","volume":"173","author":"RF Anton","year":"2004","unstructured":"Anton RF, Drobes DJ, Voronin K, Durazo-Avizu R, Moak D (2004a) Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinking. Psychopharmacology (Berl) 173:32\u201340","journal-title":"Psychopharmacology (Berl)"},{"key":"201_CR10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00004714-200102000-00013","volume":"21","author":"RF Anton","year":"2001","unstructured":"Anton RF, Moak DH, Latham PK, Waid LR, Malcolm RJ, Dias JK, Roberts JS (2001) Posttreatment results of combining naltrexone with cognitive-behavior therapy for the treatment of alcoholism. J Clin Psychopharmacol 21:72\u201377","journal-title":"J Clin Psychopharmacol"},{"key":"201_CR11","first-page":"1758","volume":"156","author":"RF Anton","year":"1999","unstructured":"Anton RF, Moak DH, Waid LR, Latham PK, Malcolm RJ, Dias JK (1999) Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. AJ Psychiatry 156:1758\u20131764","journal-title":"AJ Psychiatry"},{"key":"201_CR12","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","volume":"295","author":"RF Anton","year":"2006","unstructured":"Anton RF, O\u2019Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A (2006) Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 295:2003\u20132017","journal-title":"JAMA"},{"key":"201_CR13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/01.jcp.0000130555.63254.73","volume":"24","author":"RF Anton","year":"2004","unstructured":"Anton RF, Pettinati H, Zweben A, Kranzler HR, Johnson B, Bohn MJ, McCaul ME, Anthenelli R, Salloum I, Galloway G, Garbutt J, Swift R, Gastfriend D, Kallio A, Karhuvaara S (2004b) A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence. J Clin Psychopharmacol 24:421\u2013428","journal-title":"J Clin Psychopharmacol"},{"key":"201_CR14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1037\/0033-295X.111.1.33","volume":"111","author":"TB Baker","year":"2004","unstructured":"Baker TB, Piper ME, McCarthy DE, Majeskie MR, Fiore MC (2004) Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol Rev 111:33\u201351","journal-title":"Psychol Rev"},{"key":"201_CR15","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0091-3057(89)90298-0","volume":"34","author":"HA Baldwin","year":"1989","unstructured":"Baldwin HA, Hitchcott PK, File SE (1989) Evidence that the increased anxiety detected in the elevated plus-maze during chlordiazepoxide withdrawal is not due to enhanced noradrenergic activity. Pharmacol Biochem Behav 34:931\u2013933","journal-title":"Pharmacol Biochem Behav"},{"key":"201_CR16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF02244208","volume":"103","author":"HA Baldwin","year":"1991","unstructured":"Baldwin HA, Rassnick S, Rivier J, Koob GF, Britton KT (1991) CRF antagonist reverses the anxiogenic response to ethanol withdrawal in the rat. Psychopharmacology (Berl) 103:227\u2013232","journal-title":"Psychopharmacology (Berl)"},{"key":"201_CR17","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/01.ALC.0000075548.83053.A9","volume":"27","author":"J Balldin","year":"2003","unstructured":"Balldin J, Berglund M, Borg S, Mansson M, Bendtsen P, Franck J, Gustafsson L, Halldin J, Nilsson LH, Stolt G, Willander A (2003) A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence. Alcohol Clin Exp Res 27:1142\u20131149","journal-title":"Alcohol Clin Exp Res"},{"key":"201_CR18","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1111\/j.1360-0443.2008.02355.x","volume":"103","author":"DA Baltieri","year":"2008","unstructured":"Baltieri DA, Daro FR, Ribeiro PL, de Andrade AG (2008) Comparing topiramate with naltrexone in the treatment of alcohol dependence. Addiction 103:2035\u20132044","journal-title":"Addiction"},{"key":"201_CR20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.15288\/jsa.2004.65.136","volume":"65","author":"DA Baltieri","year":"2004","unstructured":"Baltieri DA, De Andrade AG (2004) Acamprosate in alcohol dependence: a randomized controlled efficacy study in a standard clinical setting. J Stud Alcohol 65:136\u2013139","journal-title":"J Stud Alcohol"},{"key":"201_CR21","first-page":"149","volume":"18","author":"J Barrias","year":"1997","unstructured":"Barrias J, Chabac S, Ferreira L, Fonte A, Potgieter AS, Teixeira de Sousa E (1997) Acamprosate: multicenter Portuguese efficacy and tolerance evaluation study. Psiquiatria Clinica 18:149\u2013160","journal-title":"Psiquiatria Clinica"},{"key":"201_CR22","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0376-8716(79)90019-X","volume":"4","author":"H Begleiter","year":"1979","unstructured":"Begleiter H, Porjesz B (1979) Persistence of a subacute withdrawal syndrome following chronic ethanol intake. Drug Alcohol Depend 4:353\u2013357","journal-title":"Drug Alcohol Depend"},{"key":"201_CR23","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1210\/jcem-71-3-712","volume":"71","author":"JD Berman","year":"1990","unstructured":"Berman JD, Cook DM, Buchman M, Keith LD (1990) Diminished adrenocorticotropin response to insulin-induced hypoglycemia in nondepressed, actively drinking male alcoholics. J Clin Endocrinol Metab 71:712\u2013717","journal-title":"J Clin Endocrinol Metab"},{"key":"201_CR24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0741-8329(96)00043-2","volume":"13","author":"NC Bernardy","year":"1996","unstructured":"Bernardy NC, King AC, Parsons OA, Lovallo WR (1996) Altered cortisol response in sober alcoholics: an examination of contributing factors. Alcohol 13:493\u2013498","journal-title":"Alcohol"},{"key":"201_CR25","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1530-0277.1998.tb04295.x","volume":"22","author":"J Besson","year":"1998","unstructured":"Besson J, Aeby F, Kasas A, Lehert P, Potgieter A (1998) Combined efficacy of acamprosate and disulfiram in the treatment of alcoholism: a controlled study. Alcohol Clin Exp Res 22:573\u2013579","journal-title":"Alcohol Clin Exp Res"},{"key":"201_CR26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jsat.2007.06.001","volume":"33","author":"Betty Ford Institute","year":"2007","unstructured":"Betty Ford Institute (2007) What is recovery? A working definition from the Betty Ford Institute. J Subst Abuse Treat 33:221\u2013228","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"201_CR27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.drugalcdep.2005.10.008","volume":"83","author":"A Bisaga","year":"2006","unstructured":"Bisaga A, Evans SM (2006) The acute effects of gabapentin in combination with alcohol in heavy drinkers. Drug Alcohol Depend 83(1):25\u201332","journal-title":"Drug Alcohol Depend"},{"key":"201_CR29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1600-0447.1989.tb03013.x","volume":"80","author":"K Bokstrom","year":"1989","unstructured":"Bokstrom K, Balldin J, Langstrom G (1989) Alcohol withdrawal and mood. Acta Psychiatr Scand 80:505\u2013513","journal-title":"Acta Psychiatr Scand"},{"key":"201_CR30","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1530-0277.1991.tb00552.x","volume":"15","author":"K Bokstrom","year":"1991","unstructured":"Bokstrom K, Balldin J, Langstrom G (1991) Individual mood profiles in alcohol withdrawal. Alcohol Clin Exp Res 15:508\u2013513","journal-title":"Alcohol Clin Exp Res"},{"key":"201_CR31","first-page":"263","volume":"23","author":"KT Brady","year":"1999","unstructured":"Brady KT, Sonne SC (1999) The role of stress in alcohol use, alcoholism treatment, and relapse. Alcohol Res Health 23:263\u2013271","journal-title":"Alcohol Res Health"},{"key":"201_CR32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/01.ALC.0000153544.83656.3C","volume":"29","author":"GR Breese","year":"2005","unstructured":"Breese GR, Chu K, Dayas CV, Funk D, Knapp DJ, Koob GF, Le DA, O\u2019Dell LE, Overstreet DH, Roberts AJ, Sinha R, Valdez GR, Weiss F (2005) Stress enhancement of craving during sobriety: a risk for relapse. Alcohol Clin Exp Res 29:185\u2013195","journal-title":"Alcohol Clin Exp Res"},{"key":"201_CR33","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1530-0277.2008.00706.x","volume":"32","author":"KJ Brower","year":"2008","unstructured":"Brower KJ, Myra Kim H, Strobbe S, Karam-Hage MA, Consens F, Zucker RA (2008) A randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia. Alcohol Clin Exp Res 32:1429\u20131438","journal-title":"Alcohol Clin Exp Res"},{"key":"201_CR34","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1037\/0021-843X.111.1.180","volume":"111","author":"RA Brown","year":"2002","unstructured":"Brown RA, Lejuez CW, Kahler CW, Strong DR (2002) Distress tolerance and duration of past smoking cessation attempts. J Abnorm Psychol 111:180\u2013185","journal-title":"J Abnorm Psychol"},{"key":"201_CR35","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1360-0443.1999.9433273.x","volume":"94","author":"BL Carter","year":"1999","unstructured":"Carter BL, Tiffany ST (1999) Cue-reactivity and the future of addiction research. Addiction 94:349\u2013351","journal-title":"Addiction"},{"key":"201_CR36","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/alcalc\/35.6.587","volume":"35","author":"J Chick","year":"2000","unstructured":"Chick J, Anton R, Checinski K, Croop R, Drummond DC, Farmer R, Labriola D, Marshall J, Moncrieff J, Morgan MY, Peters T, Ritson B (2000a) A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. Alcohol Alcohol 35:587\u2013593","journal-title":"Alcohol Alcohol"},{"key":"201_CR37","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/alcalc\/35.2.176","volume":"35","author":"J Chick","year":"2000","unstructured":"Chick J, Howlett H, Morgan MY, Ritson B (2000b) United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol. Alcohol Alcohol 35:176\u2013187","journal-title":"Alcohol Alcohol"},{"key":"201_CR38","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1172\/JCI33946","volume":"118","author":"JN Cleck","year":"2008","unstructured":"Cleck JN, Blendy JA (2008) Making a bad thing worse: adverse effects of stress on drug addiction. J Clin Invest 118:454\u2013461","journal-title":"J Clin Invest"},{"key":"201_CR39","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1126\/science.2882604","volume":"236","author":"CR Cloninger","year":"1987","unstructured":"Cloninger CR (1987) Neurogenetic adaptive mechanisms in alcoholism. Science 236:410\u2013416","journal-title":"Science"},{"key":"201_CR40","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1037\/0022-006X.59.4.598","volume":"59","author":"NL Cooney","year":"1991","unstructured":"Cooney NL, Kadden RM, Litt MD, Getter H (1991) Matching alcoholics to coping skills or interactional therapies: two-year follow-up results. J Consult Clin Psychol 59:598\u2013601","journal-title":"J Consult Clin Psychol"},{"key":"201_CR41","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1037\/0021-843X.106.2.243","volume":"106","author":"NL Cooney","year":"1997","unstructured":"Cooney NL, Litt MD, Morse PA, Bauer LO, Gaupp L (1997) Alcohol cue reactivity, negative-mood reactivity, and relapse in treated alcoholic men. J Abnorm Psychol 106:243\u2013250","journal-title":"J Abnorm Psychol"},{"key":"201_CR42","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1530-0277.1999.tb04099.x","volume":"23","author":"D Davidson","year":"1999","unstructured":"Davidson D, Palfai T, Bird C, Swift R (1999) Effects of naltrexone on alcohol self-administration in heavy drinkers. Alcohol Clin Exp Res 23:195\u2013203","journal-title":"Alcohol Clin Exp Res"},{"key":"201_CR43","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.addbeh.2004.03.027","volume":"29","author":"D Davidson","year":"2004","unstructured":"Davidson D, Saha C, Scifres S, Fyffe J, O\u2019Connor S, Selzer C (2004) Naltrexone and brief counseling to reduce heavy drinking in hazardous drinkers. Addict Behav 29:1253\u20131258","journal-title":"Addict Behav"},{"key":"201_CR44","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1530-0277.1996.tb01679.x","volume":"20","author":"D Davidson","year":"1996","unstructured":"Davidson D, Swift R, Fitz E (1996) Naltrexone increases the latency to drink alcohol in social drinkers. Alcohol Clin Exp Res 20:732\u2013739","journal-title":"Alcohol Clin Exp Res"},{"key":"201_CR45","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1530-0277.1985.tb05592.x","volume":"9","author":"CB Soto De","year":"1985","unstructured":"De Soto CB, O\u2019Donnell WE, Allred LJ, Lopes CE (1985) Symptomatology in alcoholics at various stages of abstinence. Alcohol Clin Exp Res 9:505\u2013512","journal-title":"Alcohol Clin Exp Res"},{"key":"201_CR46","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1097\/01.ALC.0000081617.37539.D6","volume":"27","author":"H Wit de","year":"2003","unstructured":"de Wit H, Soderpalm AH, Nikolayev L, Young E (2003) Effects of acute social stress on alcohol consumption in healthy subjects. Alcohol Clin Exp Res 27:1270\u20131277","journal-title":"Alcohol Clin Exp Res"},{"key":"201_CR47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s002130051085","volume":"146","author":"H Wit de","year":"1999","unstructured":"de Wit H, Svenson J, York A (1999) Non-specific effect of naltrexone on ethanol consumption in social drinkers. Psychopharmacology (Berl) 146:33\u201341","journal-title":"Psychopharmacology (Berl)"},{"key":"201_CR48","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0149-7634(03)00030-7","volume":"27","author":"P Witte De","year":"2003","unstructured":"De Witte P, Pinto E, Ansseau M, Verbanck P (2003) Alcohol and withdrawal: from animal research to clinical issues. Neurosci Biobehav Rev 27:189\u2013197","journal-title":"Neurosci Biobehav Rev"},{"key":"201_CR49","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/sj.npp.1300101","volume":"28","author":"DJ Drobes","year":"2003","unstructured":"Drobes DJ, Anton RF, Thomas SE, Voronin K (2003) A clinical laboratory paradigm for evaluating medication effects on alcohol consumption: naltrexone and nalmefene. Neuropsychopharmacology 28:755\u2013764","journal-title":"Neuropsychopharmacology"},{"key":"201_CR50","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1530-0277.1997.tb04450.x","volume":"21","author":"H Ehrenreich","year":"1997","unstructured":"Ehrenreich H, Schuck J, Stender N, Pilz J, Gefeller O, Schilling L, Poser W, Kaw S (1997) Endocrine and hemodynamic effects of stress versus systemic CRF in alcoholics during early and medium term abstinence. Alcohol Clin Exp Res 21:1285\u20131293","journal-title":"Alcohol Clin Exp Res"},{"key":"201_CR51","doi-asserted-by":"crossref","first-page":"393","DOI":"10.15288\/jsa.1993.54.393","volume":"54","author":"AL Errico","year":"1993","unstructured":"Errico AL, Parsons OA, King AC, Lovallo WR (1993) Attenuated cortisol response to biobehavioral stressors in sober alcoholics. J Stud Alcohol 54:393\u2013398","journal-title":"J Stud Alcohol"},{"key":"201_CR52","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.addbeh.2007.10.002","volume":"33","author":"HC Fox","year":"2008","unstructured":"Fox HC, Hong KA, Sinha R (2008) Difficulties in emotion regulation and impulse control in recently abstinent alcoholics compared with social drinkers. Addict Behav 33:388\u2013394","journal-title":"Addict Behav"},{"key":"201_CR53","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.4088\/JCP.v68n1108","volume":"68","author":"FA Furieri","year":"2007","unstructured":"Furieri FA, Nakamura-Palacios EM (2007) Gabapentin reduces alcohol consumption and craving: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 68:1691\u20131700","journal-title":"J Clin Psychiatry"},{"key":"201_CR54","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-244X-5-18","volume":"5","author":"GP Galloway","year":"2005","unstructured":"Galloway GP, Koch M, Cello R, Smith DE (2005) Pharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trial. BMC Psychiatry 5:18","journal-title":"BMC Psychiatry"},{"key":"201_CR55","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/00004714-200212000-00009","volume":"22","author":"M Gastpar","year":"2002","unstructured":"Gastpar M, Bonnet U, Boning J, Mann K, Schmidt LG, Soyka M, Wetterling T, Kielstein V, Labriola D, Croop R (2002) Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study. J Clin Psychopharmacol 22:592\u2013598","journal-title":"J Clin Psychopharmacol"},{"key":"201_CR56","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000259166","volume":"3","author":"P Geerlings","year":"1997","unstructured":"Geerlings P, Ansoms C, van den Brink W (1997) Acamprosate and prevention of relapse in alcoholics. Eur Addict Res 3:129\u2013137","journal-title":"Eur Addict Res"},{"key":"201_CR57","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00213-009-1704-3","volume":"208","author":"DT George","year":"2010","unstructured":"George DT, Herion DW, Jones CL, Phillips MJ, Hersh J, Hill D, Heilig M, Ramchandani VA, Geyer C, Spero DE, Singley ED, O\u2019Malley SS, Bishai R, Rawlings RR, Kunos G (2010) Rimonabant (SR141716) has no effect on alcohol self-administration or endocrine measures in nontreatment-seeking heavy alcohol drinkers. Psychopharmacology (Berl) 208:37\u201344","journal-title":"Psychopharmacology (Berl)"},{"key":"201_CR58","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1369-1600.2008.00111.x","volume":"13","author":"JM Gilman","year":"2008","unstructured":"Gilman JM, Hommer DW (2008) Modulation of brain response to emotional images by alcohol cues in alcohol-dependent patients. Addict Biol 13:423\u2013434","journal-title":"Addict Biol"},{"key":"201_CR59","doi-asserted-by":"crossref","first-page":"224","DOI":"10.15288\/jsa.1994.55.224","volume":"55","author":"S Glautier","year":"1994","unstructured":"Glautier S, Drummond DC (1994) Alcohol dependence and cue reactivity. J Stud Alcohol 55:224\u2013229","journal-title":"J Stud Alcohol"},{"key":"201_CR60","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/alcalc\/36.5.413","volume":"36","author":"A Gual","year":"2001","unstructured":"Gual A, Lehert P (2001) Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain. Alcohol Alcohol 36:413\u2013418","journal-title":"Alcohol Alcohol"},{"key":"201_CR61","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/j.1530-0277.2002.tb02682.x","volume":"26","author":"J Guardia","year":"2002","unstructured":"Guardia J, Caso C, Arias F, Gual A, Sanahuja J, Ramirez M, Mengual I, Gonzalvo B, Segura L, Trujols J, Casas M (2002) A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial. Alcohol Clin Exp Res 26:1381\u20131387","journal-title":"Alcohol Clin Exp Res"},{"key":"201_CR62","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00213-009-1515-6","volume":"205","author":"A Hammarberg","year":"2009","unstructured":"Hammarberg A, Jayaram-Lindstrom N, Beck O, Franck J, Reid MS (2009) The effects of acamprosate on alcohol-cue reactivity and alcohol priming in dependent patients: a randomized controlled trial. Psychopharmacology (Berl) 205:53\u201362","journal-title":"Psychopharmacology (Berl)"},{"key":"201_CR63","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.pharmthera.2006.02.001","volume":"111","author":"M Heilig","year":"2006","unstructured":"Heilig M, Egli M (2006) Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms. Pharmacol Ther 111:855\u2013876","journal-title":"Pharmacol Ther"},{"key":"201_CR64","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00004714-200106000-00006","volume":"21","author":"P Heinala","year":"2001","unstructured":"Heinala P, Alho H, Kiianmaa K, Lonnqvist J, Kuoppasalmi K, Sinclair JD (2001) Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial. J Clin Psychopharmacol 21:287\u2013292","journal-title":"J Clin Psychopharmacol"},{"key":"201_CR65","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1176\/appi.ajp.162.8.1515","volume":"162","author":"A Heinz","year":"2005","unstructured":"Heinz A, Siessmeier T, Wrase J, Buchholz HG, Grunder G, Kumakura Y, Cumming P, Schreckenberger M, Smolka MN, Rosch F, Mann K, Bartenstein P (2005) Correlation of alcohol craving with striatal dopamine synthesis capacity and D2\/3 receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patients. Am J Psychiatry 162:1515\u20131520","journal-title":"Am J Psychiatry"},{"key":"201_CR66","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1176\/ajp.161.10.1783","volume":"161","author":"A Heinz","year":"2004","unstructured":"Heinz A, Siessmeier T, Wrase J, Hermann D, Klein S, Grusser S, Flor H, Braus D, Buchholz H, Grunder G, Schrechenberger M, Smolka M, Rosch F, Mann K, Bartenstein P (2004) Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving. Am J Psychiatry 161:1783\u20131789","journal-title":"Am J Psychiatry"},{"key":"201_CR67","doi-asserted-by":"crossref","first-page":"953","DOI":"10.15288\/jsa.1977.38.953","volume":"38","author":"HI Hershon","year":"1977","unstructured":"Hershon HI (1977) Alcohol withdrawal symptoms and drinking behavior. J Stud Alcohol 38:953\u2013971","journal-title":"J Stud Alcohol"},{"key":"201_CR68","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1037\/0021-843X.84.6.644","volume":"84","author":"RL Higgins","year":"1975","unstructured":"Higgins RL, Marlatt GA (1975) Fear of interpersonal evaluation as a determinant of alcohol consumption in male social drinkers. J Abnorm Psychol 84:644\u2013651","journal-title":"J Abnorm Psychol"},{"key":"201_CR69","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00213-011-2355-8","volume":"218","author":"AE Higley","year":"2011","unstructured":"Higley AE, Crane NA, Spadoni AD, Quello SB, Goodell V, Mason BJ (2011) Craving in response to stress induction in a human laboratory paradigm predicts treatment outcome in alcohol-dependent individuals. Psychopharmacology (Berl) 218:121\u2013129","journal-title":"Psychopharmacology (Berl)"},{"key":"201_CR70","first-page":"41","volume":"9","author":"SM Holter","year":"1998","unstructured":"Holter SM, Engelmann M, Kirschke C, Liebsch G, Landgraf R, Spanagel R (1998) Long-term ethanol self-administration with repeated ethanol deprivation episodes changes ethanol drinking pattern and increases anxiety-related behaviour during ethanol deprivation in rats. Behav Pharmacol 9:41\u201348","journal-title":"Behav Pharmacol"},{"key":"201_CR71","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/13556210500223504","volume":"10","author":"MC Huang","year":"2005","unstructured":"Huang MC, Chen CH, Yu JM, Chen CC (2005) A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol dependence in Taiwan. Addict Biol 10:289\u2013292","journal-title":"Addict Biol"},{"key":"201_CR72","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1037\/0022-3514.44.6.1097","volume":"44","author":"JG Hull","year":"1983","unstructured":"Hull JG, Young RD (1983) Self-consciousness, self-esteem, and success-failure as determinants of alcohol consumption in male social drinkers. J Pers Soc Psychol 44:1097\u20131109","journal-title":"J Pers Soc Psychol"},{"key":"201_CR73","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000086176","volume":"52","author":"L Janiri","year":"2005","unstructured":"Janiri L, Martinotti G, Dario T, Reina D, Paparello F, Pozzi G, Addolorato G, Di Giannantonio M, De Risio S (2005) Anhedonia and substance-related symptoms in detoxified substance-dependent subjects: a correlation study. Neuropsychobiology 52:37\u201344","journal-title":"Neuropsychobiology"},{"key":"201_CR74","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/archpsyc.61.9.905","volume":"61","author":"BA Johnson","year":"2004","unstructured":"Johnson BA, Ait-Daoud N, Akhtar FZ, Ma JZ (2004) Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial. Arch Gen Psychiatry 61:905\u2013912","journal-title":"Arch Gen Psychiatry"},{"key":"201_CR75","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(03)13370-3","volume":"361","author":"BA Johnson","year":"2003","unstructured":"Johnson BA, Ait-Daoud N, Bowden CL, DiClemente CC, Roache JD, Lawson K, Javors MA, Ma JZ (2003) Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet 361:1677\u20131685","journal-title":"Lancet"},{"key":"201_CR76","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00213-002-1002-9","volume":"160","author":"BA Johnson","year":"2002","unstructured":"Johnson BA, Roache JD, Ait-Daoud N, Zanca NA, Velazquez M (2002) Ondansetron reduces the craving of biologically predisposed alcoholics. Psychopharmacology (Berl) 160:408\u2013413","journal-title":"Psychopharmacology (Berl)"},{"key":"201_CR77","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/jama.284.8.963","volume":"284","author":"BA Johnson","year":"2000","unstructured":"Johnson BA, Roache JD, Javors MA, DiClemente CC, Cloninger CR, Prihoda TJ, Bordnick PS, Ait-Daoud N, Hensler J (2000) Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: a randomized controlled trial. JAMA 284:963\u2013971","journal-title":"JAMA"},{"key":"201_CR78","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.298.14.1641","volume":"298","author":"BA Johnson","year":"2007","unstructured":"Johnson BA, Rosenthal N, Capece JA, Wiegand F, Mao L, Beyers K, McKay A, Ait-Daoud N, Anton RF, Ciraulo DA, Kranzler HR, Mann K, O\u2019Malley SS, Swift RM (2007) Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA 298:1641\u20131651","journal-title":"JAMA"},{"key":"201_CR79","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/alcalc\/agg052","volume":"38","author":"K Junghanns","year":"2003","unstructured":"Junghanns K, Backhaus J, Tietz U, Lange W, Bernzen J, Wetterling T, Rink L, Driessen M (2003) Impaired serum cortisol stress response is a predictor of early relapse. Alcohol Alcohol 38:189\u2013193","journal-title":"Alcohol Alcohol"},{"key":"201_CR80","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/alcalc\/agh107","volume":"40","author":"K Junghanns","year":"2005","unstructured":"Junghanns K, Tietz U, Dibbelt L, Kuether M, Jurth R, Ehrenthal D, Blank S, Backhaus J (2005) Attenuated salivary cortisol secretion under cue exposure is associated with early relapse. Alcohol Alcohol 40:80\u201385","journal-title":"Alcohol Alcohol"},{"key":"201_CR81","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1360-0443.1983.tb02510.x","volume":"78","author":"RF Kaplan","year":"1983","unstructured":"Kaplan RF, Meyer RE, Stroebel CF (1983) Alcohol dependence and responsivity to an ethanol stimulus as predictors of alcohol consumption. Br J Addict 78:259\u2013267","journal-title":"Br J Addict"},{"key":"201_CR82","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archpsyc.60.1.92","volume":"60","author":"F Kiefer","year":"2003","unstructured":"Kiefer F, Jahn H, Tarnaske T, Helwig H, Briken P, Holzbach R, Kampf P, Stracke R, Baehr M, Naber D, Wiedemann K (2003) Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study. Arch Gen Psychiatry 60:92\u201399","journal-title":"Arch Gen Psychiatry"},{"key":"201_CR83","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1097\/01.ALC.0000145688.30448.2C","volume":"28","author":"TK Killeen","year":"2004","unstructured":"Killeen TK, Brady KT, Gold PB, Simpson KN, Faldowski RA, Tyson C, Anton RF (2004) Effectiveness of naltrexone in a community treatment program. Alcohol Clin Exp Res 28:1710\u20131717","journal-title":"Alcohol Clin Exp Res"},{"key":"201_CR84","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S1054-3589(08)60910-2","volume":"42","author":"GF Koob","year":"1998","unstructured":"Koob GF (1998) Circuits, drugs, and drug addiction. Adv Pharmacol 42:978\u2013982","journal-title":"Adv Pharmacol"},{"key":"201_CR85","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/01.ALC.0000057122.36127.C2","volume":"27","author":"GF Koob","year":"2003","unstructured":"Koob GF (2003) Alcoholism: allostasis and beyond. Alcohol Clin Exp Res 27:232\u2013243","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"201_CR86","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1360-0443.2006.01586.x","volume":"101","author":"GF Koob","year":"2006","unstructured":"Koob GF (2006) The neurobiology of addiction: a neuroadaptational view relevant for diagnosis. Addiction 101(1):23\u201330","journal-title":"Addiction"},{"key":"201_CR87","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2008.06.012","volume":"59","author":"GF Koob","year":"2008","unstructured":"Koob GF (2008) A role for brain stress systems in addiction. Neuron 59:11\u201334","journal-title":"Neuron"},{"key":"201_CR88","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neubiorev.2003.11.007","volume":"27","author":"GF Koob","year":"2004","unstructured":"Koob GF, Ahmed SH, Boutrel B, Chen SA, Kenny PJ, Markou A, O\u2019Dell LE, Parsons LH, Sanna PP (2004) Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev 27:739\u2013749","journal-title":"Neurosci Biobehav Rev"},{"key":"201_CR89","first-page":"1149","volume":"164","author":"G Koob","year":"2007","unstructured":"Koob G, Kreek MJ (2007) Stress, dysregulation of drug reward pathways, and the transition to drug dependence. AJ Psychiatry 164:1149\u20131159","journal-title":"AJ Psychiatry"},{"key":"201_CR90","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1126\/science.278.5335.52","volume":"278","author":"GF Koob","year":"1997","unstructured":"Koob GF, Le Moal M (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278:52\u201358","journal-title":"Science"},{"key":"201_CR92","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0893-133X(00)00195-0","volume":"24","author":"GF Koob","year":"2001","unstructured":"Koob GF, Le Moal M (2001) Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24:97\u2013129","journal-title":"Neuropsychopharmacology"},{"key":"201_CR91","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1098\/rstb.2008.0094","volume":"363","author":"GF Koob","year":"2008","unstructured":"Koob GF, Le Moal M (2008) Review. Neurobiological mechanisms for opponent motivational processes in addiction. Philos Trans R Soc Lond B Biol Sci 363:3113\u20133123","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"201_CR93","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nrd2828","volume":"8","author":"GF Koob","year":"2009","unstructured":"Koob GF, Lloyd GK, Mason BJ (2009) Development of pharmacotherapies for drug addiction: a Rosetta stone approach. Nat Rev Drug Discovery 8:500","journal-title":"Nat Rev Drug Discovery"},{"key":"201_CR95","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/npp.2009.110","volume":"35","author":"GF Koob","year":"2010","unstructured":"Koob GF, Volkow ND (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35:217\u2013238","journal-title":"Neuropsychopharmacology"},{"key":"201_CR96","first-page":"294","volume":"23","author":"HR Kranzler","year":"2003","unstructured":"Kranzler HR, Armeli S, Tennen H, Blomqvist O, Oncken C, Petry N, Feinn R (2003) Targeted naltrexone for early problem drinkers. J Clin Psychopharmacol 23:294\u2013304","journal-title":"J Clin Psychopharmacol"},{"key":"201_CR97","first-page":"1074","volume":"22","author":"HR Kranzler","year":"1998","unstructured":"Kranzler HR, Modesto-Lowe V, Nuwayser ES (1998) Sustained-release naltrexone for alcoholism treatment: a preliminary study. Alcohol Clin Exp Res 22:1074\u20131079","journal-title":"Alcohol Clin Exp Res"},{"key":"201_CR98","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/JCP.0b013e3181ac5213","volume":"29","author":"HR Kranzler","year":"2009","unstructured":"Kranzler HR, Tennen H, Armeli S, Chan G, Covault J, Arias A, Oncken C (2009) Targeted naltrexone for problem drinkers. J Clin Psychopharmacol 29:350\u2013357","journal-title":"J Clin Psychopharmacol"},{"key":"201_CR99","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/01.ALC.0000130804.08397.29","volume":"28","author":"HR Kranzler","year":"2004","unstructured":"Kranzler HR, Wesson DR, Billot L (2004) Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial. Alcohol Clin Exp Res 28:1051\u20131059","journal-title":"Alcohol Clin Exp Res"},{"key":"201_CR100","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMoa011127","volume":"345","author":"JH Krystal","year":"2001","unstructured":"Krystal JH, Cramer JA, Krol WF, Kirk GF, Rosenheck RA (2001) Naltrexone in the treatment of alcohol dependence. N Engl J Med 345:1734\u20131739","journal-title":"N Engl J Med"},{"key":"201_CR101","first-page":"182","volume":"50","author":"D Ladewig","year":"1993","unstructured":"Ladewig D, Knecht T, Leher P, Fendl A (1993) Acamprosate\u2014a stabilizing factor in long-term withdrawal of alcoholic patients. Ther Umsch 50:182\u2013188","journal-title":"Ther Umsch"},{"key":"201_CR102","doi-asserted-by":"crossref","first-page":"530","DOI":"10.5694\/j.1326-5377.2002.tb04550.x","volume":"176","author":"NC Latt","year":"2002","unstructured":"Latt NC, Jurd S, Houseman J, Wutzke SE (2002) Naltrexone in alcohol dependence: a randomised controlled trial of effectiveness in a standard clinical setting. Med J Aust 176:530\u2013534","journal-title":"Med J Aust"},{"key":"201_CR103","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s002130000411","volume":"150","author":"AD Le","year":"2000","unstructured":"Le AD, Harding S, Juzytsch W, Watchus J, Shalev U, Shaham Y (2000) The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats. Psychopharmacology (Berl) 150:317\u2013324","journal-title":"Psychopharmacology (Berl)"},{"key":"201_CR104","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0140-6736(85)91615-0","volume":"1","author":"JP Lhuintre","year":"1985","unstructured":"Lhuintre JP, Daoust M, Moore ND, Chretien P, Saligaut C, Tran G, Bosimare F, Hillemand B (1985) Ability of calcium bis acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics. Lancet 1:1014\u20131016","journal-title":"Lancet"},{"key":"201_CR105","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.forsciint.2006.07.018","volume":"168","author":"L Lindberg","year":"2007","unstructured":"Lindberg L, Brauer S, Wollmer P, Goldberg L, Jones AW, Olsson SG (2007) Breath alcohol concentration determined with a new analyzer using free exhalation predicts almost precisely the arterial blood alcohol concentration. Forensic Sci Int 168:200\u2013207","journal-title":"Forensic Sci Int"},{"key":"201_CR106","first-page":"174","volume":"23","author":"MD Litt","year":"1999","unstructured":"Litt MD, Cooney NL (1999) Inducing craving for alcohol in the laboratory. Alcohol Res Health 23:174\u2013178","journal-title":"Alcohol Res Health"},{"key":"201_CR107","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0306-4603(90)90017-R","volume":"15","author":"MD Litt","year":"1990","unstructured":"Litt MD, Cooney NL, Kadden RM, Gaupp L (1990) Reactivity to alcohol cues and induced moods in alcoholics. Addict Behav 15:137\u2013146","journal-title":"Addict Behav"},{"key":"201_CR108","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1360-0443.2000.9568896.x","volume":"95","author":"MD Litt","year":"2000","unstructured":"Litt MD, Cooney NL, Morse P (2000) Reactivity to alcohol-related stimuli in the laboratory and in the field: predictors of craving in treated alcoholics. Addiction 95:889\u2013900","journal-title":"Addiction"},{"key":"201_CR109","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1360-0443.1995.tb01088.x","volume":"90","author":"J Littleton","year":"1995","unstructured":"Littleton J (1995) Acamprosate in alcohol dependence: how does it work? Addiction 90:1179\u20131188","journal-title":"Addiction"},{"key":"201_CR110","doi-asserted-by":"crossref","first-page":"7856","DOI":"10.1523\/JNEUROSCI.22-18-07856.2002","volume":"22","author":"X Liu","year":"2002","unstructured":"Liu X, Weiss F (2002) Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. J Neurosci 22:7856\u20137861","journal-title":"J Neurosci"},{"key":"201_CR111","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1530-0277.2000.tb02036.x","volume":"24","author":"WR Lovallo","year":"2000","unstructured":"Lovallo WR, Dickensheets SL, Myers DA, Thomas TL, Nixon SJ (2000) Blunted stress cortisol response in abstinent alcoholic and polysubstance-abusing men. Alcohol Clin Exp Res 24:651\u2013658","journal-title":"Alcohol Clin Exp Res"},{"key":"201_CR112","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0741-8329(95)02030-6","volume":"13","author":"DJ Macey","year":"1996","unstructured":"Macey DJ, Schulteis G, Heinrichs SC, Koob GF (1996) Time-dependent quantifiable withdrawal from ethanol in the rat: effect of method of dependence induction. Alcohol 13:163\u2013170","journal-title":"Alcohol"},{"key":"201_CR113","first-page":"71","volume-title":"Relapse prevention","author":"G Marlatt","year":"1985","unstructured":"Marlatt G (1985) Situational determinants of relapse and skill-training interventions. In: Marlatt G, Gordan JR (eds) Relapse prevention. Guilford Press, New York, pp 71\u2013127"},{"key":"201_CR114","first-page":"191","volume":"25","author":"GA Marlatt","year":"1979","unstructured":"Marlatt GA (1979) A cognitive-behavioral model of the relapse process. NIDA Res Monogr 25:191\u2013200","journal-title":"NIDA Res Monogr"},{"key":"201_CR115","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0306-4603(90)90048-3","volume":"15","author":"GA Marlatt","year":"1990","unstructured":"Marlatt GA (1990) Cue exposure and relapse prevention in the treatment of addictive behaviors. Addict Behav 15:395\u2013399","journal-title":"Addict Behav"},{"key":"201_CR116","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1360-0443.1984.tb03867.x","volume":"79","author":"GA Marlatt","year":"1984","unstructured":"Marlatt GA, George WH (1984) Relapse prevention: introduction and overview of the model. Br J Addict 79:261\u2013273","journal-title":"Br J Addict"},{"key":"201_CR117","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.nic.2007.07.004","volume":"17","author":"D Martinez","year":"2007","unstructured":"Martinez D, Kim JH, Krystal J, Abi-Dargham A (2007) Imaging the neurochemistry of alcohol and substance abuse. Neuroimaging Clin N Am 17:539\u2013555","journal-title":"Neuroimaging Clin N Am"},{"key":"201_CR118","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/00952990701877078","volume":"34","author":"G Martinotti","year":"2008","unstructured":"Martinotti G, Cloninger CR, Janiri L (2008a) Temperament and character inventory dimensions and anhedonia in detoxified substance-dependent subjects. Am J Drug Alcohol Abuse 34:177\u2013183","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"9","key":"201_CR119","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1177\/0269881109102623","volume":"24","author":"G Martinotti","year":"2010","unstructured":"Martinotti G, Di Nicola M, Tedeschi D, Andreoli S, Reina D, Pomponi M, Mazza M, Romanelli R, Moroni N, De Filippis R, Di Giannantonio M, Pozzi G, Bria P, Janiri L (2010) Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial. J Psychopharmacol 24(9):1367\u20131374","journal-title":"J Psychopharmacol"},{"key":"201_CR120","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/10826080701202429","volume":"43","author":"G Martinotti","year":"2008","unstructured":"Martinotti G, Nicola MD, Reina D, Andreoli S, Foca F, Cunniff A, Tonioni F, Bria P, Janiri L (2008b) Alcohol protracted withdrawal syndrome: the role of anhedonia. Subst Use Misuse 43:271\u2013284","journal-title":"Subst Use Misuse"},{"key":"201_CR121","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1517\/14656566.6.12.2103","volume":"6","author":"BJ Mason","year":"2005","unstructured":"Mason BJ (2005) Acamprosate in the treatment of alcohol dependence. Expert Opin Pharmacother 6:2103\u20132115","journal-title":"Expert Opin Pharmacother"},{"key":"201_CR122","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jpsychires.2006.02.002","volume":"40","author":"BJ Mason","year":"2006","unstructured":"Mason BJ, Goodman AM, Chabac S, Lehert P (2006) Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation. J Psychiatr Res 40:383\u2013393","journal-title":"J Psychiatr Res"},{"key":"201_CR123","volume-title":"Evaluation of craving and sleep in a human laboratory study of acamprosate, naltrexone and placebo in alcohol dependent volunteers 15th Biennial International Society for Biomedical Research on alcoholism conference","author":"BJ Mason","year":"2010","unstructured":"Mason BJ, Higley AE, Crane NA, Goodell V (2010) Evaluation of craving and sleep in a human laboratory study of acamprosate, naltrexone and placebo in alcohol dependent volunteers 15th Biennial International Society for Biomedical Research on alcoholism conference. France, Paris"},{"key":"201_CR124","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1521-0391.2009.00013.x","volume":"19","author":"BJ Mason","year":"2010","unstructured":"Mason BJ, Lehert P (2010) The effects of current subsyndromal psychiatric symptoms or past psychopathology on alcohol dependence treatment outcomes and acamprosate efficacy. Am J Addict 19:147\u2013154","journal-title":"Am J Addict"},{"key":"201_CR125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00213-008-1192-x","volume":"200","author":"BJ Mason","year":"2008","unstructured":"Mason BJ, Light JM, Escher T, Drobes DJ (2008) Effect of positive and negative affective stimuli and beverage cues on measures of craving in non treatment-seeking alcoholics. Psychopharmacology (Berl) 200:141\u2013150","journal-title":"Psychopharmacology (Berl)"},{"key":"201_CR126","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1369-1600.2008.00133.x","volume":"14","author":"BJ Mason","year":"2009","unstructured":"Mason BJ, Light JM, Williams LD, Drobes DJ (2009) Proof-of-concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin. Addict Biol 14:73\u201383","journal-title":"Addict Biol"},{"key":"201_CR127","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1530-0277.1994.tb00098.x","volume":"18","author":"BJ Mason","year":"1994","unstructured":"Mason BJ, Ritvo EC, Morgan RO, Salvato FR, Goldberg G, Welch B, Mantero-Atienza E (1994) A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence. Alcohol Clin Exp Res 18:1162\u20131167","journal-title":"Alcohol Clin Exp Res"},{"key":"201_CR128","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/archpsyc.56.8.719","volume":"56","author":"BJ Mason","year":"1999","unstructured":"Mason BJ, Salvato FR, Williams LD, Ritvo EC, Cutler RB (1999) A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence. Arch Gen Psychiatry 56:719\u2013724","journal-title":"Arch Gen Psychiatry"},{"key":"201_CR129","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0893-133X(99)00147-5","volume":"22","author":"ME McCaul","year":"2000","unstructured":"McCaul ME, Wand GS, Eissenberg T, Rohde CA, Cheskin LJ (2000) Naltrexone alters subjective and psychomotor responses to alcohol in heavy drinking subjects. Neuropsychopharmacology 22:480\u2013492","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"201_CR130","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/j.1530-0277.2006.00156.x","volume":"30","author":"JE McGeary","year":"2006","unstructured":"McGeary JE et al (2006) Genetic moderators of naltrexone\u2019s effects on alcohol cue reactivity. Alcohol Clin Exp Res 30(8):1288\u20131296","journal-title":"Alcohol Clin Exp Res"},{"key":"201_CR131","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0005-7967(74)90094-1","volume":"12","author":"PM Miller","year":"1974","unstructured":"Miller PM, Hersen M, Eisler RM, Hilsman G (1974) Effects of social stress on operant drinking of alcoholics and social drinkers. Behav Res Ther 12:67\u201372","journal-title":"Behav Res Ther"},{"key":"201_CR132","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1530-0277.2007.00592.x","volume":"32","author":"R Miranda Jr","year":"2008","unstructured":"Miranda R Jr, MacKillop J, Monti PM, Rohsenow DJ, Tidey J, Gwaltney C, Swift R, Ray L, McGeary J (2008) Effects of topiramate on urge to drink and the subjective effects of alcohol: a preliminary laboratory study. Alcohol Clin Exp Res 32:489\u2013497","journal-title":"Alcohol Clin Exp Res"},{"key":"201_CR134","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0376-8716(97)00134-8","volume":"49","author":"V Modesto-Lowe","year":"1997","unstructured":"Modesto-Lowe V, Burleson JA, Hersh D, Bauer LO, Kranzler HR (1997) Effects of naltrexone on cue-elicited craving for alcohol and cocaine. Drug Alcohol Depend 49:9\u201316","journal-title":"Drug Alcohol Depend"},{"key":"201_CR135","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1530-0277.1997.tb03818.x","volume":"21","author":"C Moller","year":"1997","unstructured":"Moller C, Wiklund L, Thorsell A, Hyytia P, Heilig M (1997) Decreased measures of experimental anxiety in rats bred for high alcohol preference. Alcohol Clin Exp Res 21:656\u2013660","journal-title":"Alcohol Clin Exp Res"},{"key":"201_CR136","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1037\/0021-843X.96.2.122","volume":"96","author":"PM Monti","year":"1987","unstructured":"Monti PM, Binkoff JA, Abrams DB, Zwick WR, Nirenberg TD, Liepman MR (1987) Reactivity of alcoholics and nonalcoholics to drinking cues. J Abnorm Psychol 96:122\u2013126","journal-title":"J Abnorm Psychol"},{"key":"201_CR137","first-page":"1386","volume":"23","author":"PM Monti","year":"1999","unstructured":"Monti PM, Rohsenow DJ, Hutchison KE, Swift RM, Mueller TI, Colby SM, Brown RA, Gulliver SB, Gordon A, Abrams DB (1999) Naltrexone\u2019s effect on cue-elicited craving among alcoholics in treatment. Alcohol Clin Exp Res 23:1386\u20131394","journal-title":"Alcohol Clin Exp Res"},{"key":"201_CR138","doi-asserted-by":"crossref","first-page":"235","DOI":"10.15288\/jsa.1993.54.235","volume":"54","author":"PM Monti","year":"1993","unstructured":"Monti PM, Rohsenow DJ, Rubonis AV, Niaura RS, Sirota AD, Colby SM, Abrams DB (1993) Alcohol cue reactivity: effects of detoxification and extended exposure. J Stud Alcohol 54:235\u2013245","journal-title":"J Stud Alcohol"},{"key":"201_CR139","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/j.1360-0443.2006.01555.x","volume":"101","author":"KC Morley","year":"2006","unstructured":"Morley KC, Teesson M, Reid SC, Sannibale C, Thomson C, Phung N, Weltman M, Bell JR, Richardson K, Haber PS (2006) Naltrexone versus acamprosate in the treatment of alcohol dependence: a multi-centre, randomized, double-blind, placebo-controlled trial. Addiction 101:1451\u20131462","journal-title":"Addiction"},{"key":"201_CR140","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1046\/j.1360-0443.2001.961115654.x","volume":"96","author":"PL Morris","year":"2001","unstructured":"Morris PL, Hopwood M, Whelan G, Gardiner J, Drummond E (2001) Naltrexone for alcohol dependence: a randomized controlled trial. Addiction 96:1565\u20131573","journal-title":"Addiction"},{"key":"201_CR141","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0741-8329(85)90133-8","volume":"2","author":"D Mossberg","year":"1985","unstructured":"Mossberg D, Liljeberg P, Borg S (1985) Clinical conditions in alcoholics during long-term abstinence: a descriptive, longitudinal treatment study. Alcohol 2:551\u2013553","journal-title":"Alcohol"},{"key":"201_CR142","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1530-0277.2006.00299.x","volume":"31","author":"H Myrick","year":"2007","unstructured":"Myrick H, Anton R, Voronin K, Wang W, Henderson S (2007) A double-blind evaluation of gabapentin on alcohol effects and drinking in a clinical laboratory paradigm. Alcohol Clin Exp Res 31:221\u2013227","journal-title":"Alcohol Clin Exp Res"},{"key":"201_CR143","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/archpsyc.65.4.466","volume":"65","author":"H Myrick","year":"2008","unstructured":"Myrick H, Anton RF, Li X, Henderson S, Randall PK, Voronin K (2008) Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people. Arch Gen Psychiatry 65:466\u2013475","journal-title":"Arch Gen Psychiatry"},{"key":"201_CR144","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/alcalc\/agg038","volume":"38","author":"K Namkoong","year":"2003","unstructured":"Namkoong K, Lee BO, Lee PG, Choi MJ, Lee E (2003) Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study. Alcohol Alcohol 38:135\u2013141","journal-title":"Alcohol Alcohol"},{"key":"201_CR145","first-page":"336","volume":"1","author":"CB Nemeroff","year":"1996","unstructured":"Nemeroff CB (1996) The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol Psychiatry 1:336\u2013342","journal-title":"Mol Psychiatry"},{"issue":"Suppl 2","key":"201_CR146","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1046\/j.1360-0443.95.8s2.4.x","volume":"95","author":"R Niaura","year":"2000","unstructured":"Niaura R (2000) Cognitive social learning and related perspectives on drug craving. Addiction 95(Suppl 2): S155\u2013S163","journal-title":"Addiction"},{"key":"201_CR147","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s00787-003-0327-1","volume":"12","author":"H Niederhofer","year":"2003","unstructured":"Niederhofer H, Staffen W (2003) Acamprosate and its efficacy in treating alcohol dependent adolescents. Eur Child Adolesc Psychiatry 12:144\u2013148","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"201_CR148","doi-asserted-by":"crossref","unstructured":"O\u2019Connor AB, Lang VJ (2007) Baclofen not comparable to diazepam for alcohol withdrawal. Am J Med 120: e5; author reply e7","DOI":"10.1016\/j.amjmed.2006.03.041"},{"key":"201_CR149","first-page":"65","volume":"150","author":"TJ O\u2019Farrell","year":"1995","unstructured":"O\u2019Farrell TJ, Allen JP, Litten RZ (1995) Disulfiram (antabuse) contracts in treatment of alcoholism. NIDA Res Monogr 150:65\u201391","journal-title":"NIDA Res Monogr"},{"key":"201_CR150","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archpsyc.1992.01820110045007","volume":"49","author":"SS O\u2019Malley","year":"1992","unstructured":"O\u2019Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B (1992) Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch Gen Psychiatry 49:881\u2013887","journal-title":"Arch Gen Psychiatry"},{"key":"201_CR151","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s002130100919","volume":"160","author":"SS O\u2019Malley","year":"2002","unstructured":"O\u2019Malley SS, Krishnan-Sarin S, Farren C, Sinha R, Kreek MJ (2002) Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis. Psychopharmacology (Berl) 160:19\u201329","journal-title":"Psychopharmacology (Berl)"},{"key":"201_CR153","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.euroneuro.2007.02.012","volume":"17","author":"W Ooteman","year":"2007","unstructured":"Ooteman W, Koeter MW, Verheul R, Schippers GM, van den Brink W (2007) The effect of naltrexone and acamprosate on cue-induced craving, autonomic nervous system and neuroendocrine reactions to alcohol-related cues in alcoholics. Eur Neuropsychopharmacol 17:558\u2013566","journal-title":"Eur Neuropsychopharmacol"},{"key":"201_CR154","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00019442-199700540-00007","volume":"5","author":"D Oslin","year":"1997","unstructured":"Oslin D, Liberto JG, O\u2019Brien J, Krois S, Norbeck J (1997) Naltrexone as an adjunctive treatment for older patients with alcohol dependence. Am J Geriatr Psychiatry 5:324\u2013332","journal-title":"Am J Geriatr Psychiatry"},{"key":"201_CR155","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1530-0277.2008.00698.x","volume":"32","author":"DW Oslin","year":"2008","unstructured":"Oslin DW, Lynch KG, Pettinati HM, Kampman KM, Gariti P, Gelfand L, Ten Have T, Wortman S, Dundon W, Dackis C, Volpicelli JR, O\u2019Brien CP (2008) A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention. Alcohol Clin Exp Res 32:1299\u20131308","journal-title":"Alcohol Clin Exp Res"},{"key":"201_CR156","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1530-0277.2002.tb02665.x","volume":"26","author":"DH Overstreet","year":"2002","unstructured":"Overstreet DH, Knapp DJ, Breese GR (2002) Accentuated decrease in social interaction in rats subjected to repeated ethanol withdrawals. Alcohol Clin Exp Res 26:1259\u20131268","journal-title":"Alcohol Clin Exp Res"},{"key":"201_CR157","first-page":"239","volume":"30","author":"FM Paille","year":"1995","unstructured":"Paille FM, Guelfi JD, Perkins AC, Royer RJ, Steru L, Parot P (1995) Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol. Alcohol Alcohol 30:239\u2013247","journal-title":"Alcohol Alcohol"},{"key":"201_CR158","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1037\/1064-1297.7.3.266","volume":"7","author":"T Palfai","year":"1999","unstructured":"Palfai T, Davidson D, Swift R (1999) Influence of naltrexone on cue-elicited craving among hazardous drinkers: the moderational role of positive outcome expectancies. Exp Clin Psychopharmacol 7:266\u2013273","journal-title":"Exp Clin Psychopharmacol"},{"key":"201_CR159","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/978-1-4612-2878-3_44","volume-title":"Novel pharmacological interventions for alcoholism","author":"I Pelc","year":"1992","unstructured":"Pelc I, Le Bon O, Verbanck P, Lehert PH, Opsomer L (1992) Calcium-acetylhomotaurinate for maintaining abstinence in weaned alcoholic patients: a placebo-controlled double-blind multi-centre study, in novel pharmacological interventions for alcoholism. In: Naranjo CASE (ed) Novel pharmacological interventions for alcoholism. Springer, New York, pp 348\u2013352"},{"key":"201_CR160","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1192\/bjp.171.1.73","volume":"171","author":"I Pelc","year":"1997","unstructured":"Pelc I, Verbanck P, Le Bon O, Gavrilovic M, Lion K, Lehert P (1997) Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients. A 90-day placebo-controlled dose-finding study. Br J Psychiatry 171:73\u201377","journal-title":"Br J Psychiatry"},{"key":"201_CR161","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.biopsych.2005.02.016","volume":"57","author":"IL Petrakis","year":"2005","unstructured":"Petrakis IL, Poling J, Levinson C, Nich C, Carroll K, Rounsaville B (2005) Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders. Biol Psychiatry 57:1128\u20131137","journal-title":"Biol Psychiatry"},{"key":"201_CR162","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/archpsyc.1987.01800230050009","volume":"44","author":"RK Pitman","year":"1987","unstructured":"Pitman RK, Orr SP, Forgue DF, de Jong JB, Claiborn JM (1987) Psychophysiologic assessment of posttraumatic stress disorder imagery in Vietnam combat veterans. Arch Gen Psychiatry 44:970\u2013975","journal-title":"Arch Gen Psychiatry"},{"key":"201_CR163","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bspc.2007.04.001","volume":"2","author":"MH Plawecki","year":"2007","unstructured":"Plawecki MH, Decarlo R, Ramchandani VA, O\u2019Connor S (2007) Improved transformation of morphometric measurements for a priori parameter estimation in a physiologically-based pharmacokinetic model of ethanol. Biomed Signal Process Control 2:97\u2013110","journal-title":"Biomed Signal Process Control"},{"key":"201_CR164","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1109\/TBME.2008.919132","volume":"55","author":"MH Plawecki","year":"2008","unstructured":"Plawecki MH, Han JJ, Doerschuk PC, Ramchandani VA, O\u2019Connor SJ (2008) Physiologically based pharmacokinetic (PBPK) models for ethanol. IEEE Trans Biomed Eng 55:2691\u20132700","journal-title":"IEEE Trans Biomed Eng"},{"key":"201_CR165","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1111\/j.1360-0443.1997.tb02873.x","volume":"92","author":"F Poldrugo","year":"1997","unstructured":"Poldrugo F (1997) Acamprosate treatment in a long-term community-based alcohol rehabilitation programme. Addiction 92:1537\u20131546","journal-title":"Addiction"},{"key":"201_CR166","first-page":"286","volume":"29","author":"VA Ramchandani","year":"2006","unstructured":"Ramchandani VA, O\u2019Connor S (2006) Studying alcohol elimination using the alcohol clamp method. Alcohol Res Health 29:286\u2013290","journal-title":"Alcohol Res Health"},{"key":"201_CR167","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1530-0277.2001.tb02308.x","volume":"25","author":"DD Rasmussen","year":"2001","unstructured":"Rasmussen DD, Mitton DR, Green J, Puchalski S (2001) Chronic daily ethanol and withdrawal: 2. Behavioral changes during prolonged abstinence. Alcohol Clin Exp Res 25:999\u20131005","journal-title":"Alcohol Clin Exp Res"},{"key":"201_CR168","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0006-8993(93)91352-S","volume":"605","author":"S Rassnick","year":"1993","unstructured":"Rassnick S, Heinrichs SC, Britton KT, Koob GF (1993) Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res 605:25\u201332","journal-title":"Brain Res"},{"key":"201_CR169","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archpsyc.64.9.1069","volume":"64","author":"LA Ray","year":"2007","unstructured":"Ray LA, Hutchison KE (2007) Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study. Arch Gen Psychiatry 64:1069\u20131077","journal-title":"Arch Gen Psychiatry"},{"key":"201_CR170","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/sj.npp.1300840","volume":"31","author":"M Roberto","year":"2006","unstructured":"Roberto M, Bajo M, Crawford E, Madamba SG, Siggins GR (2006) Chronic ethanol exposure and protracted abstinence alter NMDA receptors in central amygdala. Neuropsychopharmacology 31:988\u2013996","journal-title":"Neuropsychopharmacology"},{"key":"201_CR171","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0741-8329(85)90123-5","volume":"2","author":"SM Roelofs","year":"1985","unstructured":"Roelofs SM (1985) Hyperventilation, anxiety, craving for alcohol: a subacute alcohol withdrawal syndrome. Alcohol 2:501\u2013505","journal-title":"Alcohol"},{"key":"201_CR172","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0741-8329(87)90046-2","volume":"4","author":"SM Roelofs","year":"1987","unstructured":"Roelofs SM, Dikkenberg GM (1987) Hyperventilation and anxiety: alcohol withdrawal symptoms decreasing with prolonged abstinence. Alcohol 4:215\u2013220","journal-title":"Alcohol"},{"key":"201_CR173","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1037\/0021-843X.109.4.738","volume":"109","author":"DJ Rohsenow","year":"2000","unstructured":"Rohsenow DJ, Monti PM, Hutchison KE, Swift RM, Colby SM, Kaplan GB (2000) Naltrexone\u2019s effects on reactivity to alcohol cues among alcoholic men. J Abnorm Psychol 109:738\u2013742","journal-title":"J Abnorm Psychol"},{"key":"201_CR174","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1037\/0022-006X.62.3.620","volume":"62","author":"DJ Rohsenow","year":"1994","unstructured":"Rohsenow DJ, Monti PM, Rubonis AV, Sirota AD, Niaura RS, Colby SM, Wunschel SM, Abrams DB (1994) Cue reactivity as a predictor of drinking among male alcoholics. J Consult Clin Psychol 62:620\u2013626","journal-title":"J Consult Clin Psychol"},{"key":"201_CR175","first-page":"65","volume":"51","author":"JP Roussaux","year":"1996","unstructured":"Roussaux JP, Hers D, Ferauge M (1996) Does acamprosate diminish the appetite for alcohol in weaned alcoholics? J Pharm Belg 51:65\u201368","journal-title":"J Pharm Belg"},{"key":"201_CR177","doi-asserted-by":"crossref","first-page":"487","DOI":"10.15288\/jsa.1994.55.487","volume":"55","author":"AV Rubonis","year":"1994","unstructured":"Rubonis AV, Colby SM, Monti PM, Rohsenow DJ, Gulliver SB, Sirota AD (1994) Alcohol cue reactivity and mood induction in male and female alcoholics. J Stud Alcohol 55:487\u2013494","journal-title":"J Stud Alcohol"},{"key":"201_CR178","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1369-1600.2006.00012.x","volume":"11","author":"C Sanchis-Segura","year":"2006","unstructured":"Sanchis-Segura C, Spanagel R (2006) Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addict Biol 11:2\u201338","journal-title":"Addict Biol"},{"key":"201_CR179","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/archpsyc.1996.01830080023006","volume":"53","author":"H Sass","year":"1996","unstructured":"Sass H, Soyka M, Mann K, Zieglgansberger W (1996) Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence. Arch Gen Psychiatry 53:673\u2013680","journal-title":"Arch Gen Psychiatry"},{"key":"201_CR180","doi-asserted-by":"crossref","first-page":"629","DOI":"10.15288\/jsa.1994.55.629","volume":"55","author":"MA Sayette","year":"1994","unstructured":"Sayette MA, Monti PM, Rohsenow DJ, Gulliver SB, Colby SM, Sirota AD, Niaura R, Abrams DB (1994) The effects of cue exposure on reaction time in male alcoholics. J Stud Alcohol 55:629\u2013633","journal-title":"J Stud Alcohol"},{"key":"201_CR181","doi-asserted-by":"crossref","first-page":"34","DOI":"10.15288\/jsa.1990.51.34","volume":"51","author":"MA Schuckit","year":"1990","unstructured":"Schuckit MA, Irwin M, Brown SA (1990) The history of anxiety symptoms among 171 primary alcoholics. J Stud Alcohol 51:34\u201341","journal-title":"J Stud Alcohol"},{"key":"201_CR182","doi-asserted-by":"crossref","first-page":"587","DOI":"10.15288\/qjsa.1970.31.587","volume":"31","author":"BM Segal","year":"1970","unstructured":"Segal BM, Kushnarev VM, Urakov IG, Misionzhnik EU (1970) Alcoholism and disruption of the activity of deep cerebral structures. Clinical-laboratory research. Q J Stud Alcohol 31:587\u2013601","journal-title":"Q J Stud Alcohol"},{"key":"201_CR183","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1530-0277.1994.tb00054.x","volume":"18","author":"EM Sellers","year":"1994","unstructured":"Sellers EM, Toneatto T, Romach MK, Somer GR, Sobell LC, Sobell MB (1994) Clinical efficacy of the 5-HT3 antagonist ondansetron in alcohol abuse and dependence. Alcohol Clin Exp Res 18:879\u2013885","journal-title":"Alcohol Clin Exp Res"},{"key":"201_CR184","unstructured":"Singleton E, Tiffany S, Henningfield J (1994) Development and validation of a new questionnaire to assess craving for alcohol: problems of drug dependence. In: Proceeding of the 56th annual meeting, The College on Problems of Drug Dependence. National Institute on Drug Abuse, Rockville, MD, p 289"},{"key":"201_CR185","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1369-1600.2008.00134.x","volume":"14","author":"R Sinha","year":"2009","unstructured":"Sinha R (2009) Modeling stress and drug craving in the laboratory: implications for addiction treatment development. Addict Biol 14:84\u201398","journal-title":"Addict Biol"},{"key":"201_CR186","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/npp.2008.78","volume":"34","author":"R Sinha","year":"2009","unstructured":"Sinha R, Fox HC, Hong KA, Bergquist K, Bhagwagar Z, Siedlarz KM (2009) Enhanced negative emotion and alcohol craving, and altered physiological responses following stress and cue exposure in alcohol dependent individuals. Neuropsychopharmacology 34:1198\u20131208","journal-title":"Neuropsychopharmacology"},{"key":"201_CR187","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s002130000499","volume":"152","author":"R Sinha","year":"2000","unstructured":"Sinha R, Fuse T, Aubin LR, O\u2019Malley SS (2000) Psychological stress, drug-related cues and cocaine craving. Psychopharmacology (Berl) 152:140\u2013148","journal-title":"Psychopharmacology (Berl)"},{"key":"201_CR188","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/JCP.0b013e318172b8bc","volume":"28","author":"M Soyka","year":"2008","unstructured":"Soyka M, Koller G, Schmidt P, Lesch OM, Leweke M, Fehr C, Gann H, Mann KF (2008) Cannabinoid receptor 1 blocker rimonabant (SR 141716) for treatment of alcohol dependence: results from a placebo-controlled, double-blind trial. J Clin Psychopharmacol 28:317\u2013324","journal-title":"J Clin Psychopharmacol"},{"key":"201_CR189","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/j.1530-0277.2006.00180.x","volume":"30","author":"L Staner","year":"2006","unstructured":"Staner L, Boeijinga P, Danel T, Gendre I, Muzet M, Landron F, Luthringer R (2006) Effects of acamprosate on sleep during alcohol withdrawal: a double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects. Alcohol Clin Exp Res 30:1492\u20131499","journal-title":"Alcohol Clin Exp Res"},{"key":"201_CR191","first-page":"207","volume":"23","author":"RM Swift","year":"1999","unstructured":"Swift RM (1999) Medications and alcohol craving. Alcohol Res Health 23:207\u2013213","journal-title":"Alcohol Res Health"},{"key":"201_CR193","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/alcalc\/35.2.202","volume":"35","author":"E Tempesta","year":"2000","unstructured":"Tempesta E, Janiri L, Bignamini A, Chabac S, Potgieter A (2000) Acamprosate and relapse prevention in the treatment of alcohol dependence: a placebo-controlled study. Alcohol Alcohol 35:202\u2013209","journal-title":"Alcohol Alcohol"},{"key":"201_CR194","first-page":"215","volume":"23","author":"ST Tiffany","year":"1999","unstructured":"Tiffany ST (1999) Cognitive concepts of craving. Alcohol Res Health 23:215\u2013224","journal-title":"Alcohol Res Health"},{"key":"201_CR195","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1369-1600.2008.00131.x","volume":"14","author":"M Uhart","year":"2009","unstructured":"Uhart M, Wand GS (2009) Stress, alcohol and drug interaction: an update of human research. Addict Biol 14:43\u201364","journal-title":"Addict Biol"},{"key":"201_CR196","first-page":"13N","volume":"45","author":"N Volkow","year":"2004","unstructured":"Volkow N (2004) Imaging the addicted brain: from molecules to behavior. J Nucl Med 45:13N\u201324N","journal-title":"J Nucl Med"},{"key":"201_CR197","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1001\/archpsyc.1992.01820110040006","volume":"49","author":"JR Volpicelli","year":"1992","unstructured":"Volpicelli JR, Alterman AI, Hayashida M, O\u2019Brien CP (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49:876\u2013880","journal-title":"Arch Gen Psychiatry"},{"key":"201_CR198","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/archpsyc.1997.01830200071010","volume":"54","author":"JR Volpicelli","year":"1997","unstructured":"Volpicelli JR, Rhines KC, Rhines JS, Volpicelli LA, Alterman AI, O\u2019Brien CP (1997) Naltrexone and alcohol dependence. Role of subject compliance. Arch Gen Psychiatry 54:737\u2013742","journal-title":"Arch Gen Psychiatry"},{"key":"201_CR199","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0741-8329(96)81678-8","volume":"13","author":"A Voltaire-Carlsson","year":"1996","unstructured":"Voltaire-Carlsson A, Hiltunen AJ, Koechling UM, Borg S (1996) Effects of long-term abstinence on psychological functioning: a prospective longitudinal analysis comparing alcohol-dependent patients and healthy volunteers. Alcohol 13:415\u2013421","journal-title":"Alcohol"},{"key":"201_CR200","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.2307\/1131892","volume":"67","author":"S Vuchinich","year":"1996","unstructured":"Vuchinich S, Angelelli J, Gatherum A (1996) Context and development in family problem solving with preadolescent children. Child Dev 67:1276\u20131288","journal-title":"Child Dev"},{"key":"201_CR201","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1210\/jcem-72-6-1290","volume":"72","author":"GS Wand","year":"1991","unstructured":"Wand GS, Dobs AS (1991) Alterations in the hypothalamic-pituitary-adrenal axis in actively drinking alcoholics. J Clin Endocrinol Metab 72:1290\u20131295","journal-title":"J Clin Endocrinol Metab"},{"key":"201_CR202","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/13556210020040244","volume":"6","author":"KI Watanabe","year":"2001","unstructured":"Watanabe KI, Ogihara-Hashizume A, Kobayashi Y, Mitsushio H, Komiyama T (2001) Impaired sleep during the post-alcohol withdrawal period in alcoholic patients. Addict Biol 6:163\u2013169","journal-title":"Addict Biol"},{"key":"201_CR203","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/1355621031000117464","volume":"8","author":"A Weinstein","year":"2003","unstructured":"Weinstein A, Feldtkeller B, Feeney A, Lingford-Hughes A, Nutt D (2003) A pilot study on the effects of treatment with acamprosate on craving for alcohol in alcohol-dependent patients. Addict Biol 8:229\u2013232","journal-title":"Addict Biol"},{"key":"201_CR204","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0140-6736(96)91682-7","volume":"347","author":"AB Whitworth","year":"1996","unstructured":"Whitworth AB, Fischer F, Lesch OM, Nimmerrichter A, Oberbauer H, Platz T, Potgieter A, Walter H, Fleischhacker WW (1996) Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. Lancet 347:1438\u20131442","journal-title":"Lancet"},{"key":"201_CR205","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/j.1530-0277.2008.00700.x","volume":"32","author":"US Zimmermann","year":"2008","unstructured":"Zimmermann US, Mick I, Vitvitskyi V, Plawecki MH, Mann KF, O\u2019Connor S (2008) Development and pilot validation of computer-assisted self-infusion of ethanol (CASE): a new method to study alcohol self-administration in humans. Alcohol Clin Exp Res 32:1321\u20131328","journal-title":"Alcohol Clin Exp Res"},{"key":"201_CR206","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s002130100773","volume":"158","author":"EP Zorrilla","year":"2001","unstructured":"Zorrilla EP, Valdez GR, Weiss F (2001) Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats. Psychopharmacology (Berl) 158:374\u2013381","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Current Topics in Behavioral Neurosciences","Behavioral Neurobiology of Alcohol Addiction"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-28720-6_201","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T05:04:10Z","timestamp":1597467850000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-28720-6_201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"ISBN":["9783642287190","9783642287206"],"references-count":198,"aliases":["10.1007\/7854_2012_201"],"URL":"https:\/\/doi.org\/10.1007\/978-3-642-28720-6_201","relation":{},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"value":"1866-3370","type":"print"},{"value":"1866-3389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}